Ignite Creation Date:
2024-05-06 @ 8:11 PM
Last Modification Date:
2024-10-26 @ 3:22 PM
Study NCT ID:
NCT06286254
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-29
First Post:
2024-02-22
Brief Title:
Study of Safety and Efficacy of the Drug Cycloferone in Patients With Acute Respiratory Viral Infection
Sponsor:
POLYSAN Scientific Technological Pharmaceutical Company
Organization:
POLYSAN Scientific Technological Pharmaceutical Company
Study Overview
Official Title:
Non-interventional Prospective Study of Safety and Efficacy of the Drug Cycloferone NTFF POLYSAN Ltd Russia in Patients With Acute Respiratory Viral Infection at the Outpatient Stage
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The study will collect the information on clinical effects and safety of the basic therapy of acute respiratory viral infection ARVI Cycloferone and basic therapy of ARVI1 Arbidol in real-life clinical settings
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None